Supernus Pharmaceuticals, Inc. (SUPN) SEC Filings — 2025
20 SEC filings for Supernus Pharmaceuticals, Inc. (SUPN) in 2025.
Filings
- Supernus Swings to Loss Amid Sage Acquisition, ZURZUVAE Launch — 10-Q · Nov 6, 2025
- Supernus Pharmaceuticals, Inc. 8-K Filing — 8-K · Nov 4, 2025
- Supernus Pharmaceuticals Files 8-K on Financials — 8-K · Oct 21, 2025
- Supernus Pharmaceuticals Files 8-K/A Amendment — 8-K/A · Oct 16, 2025
- Supernus Q2 Revenue Jumps 21%, Net Income Dips Amid Rising Costs — 10-Q · Aug 5, 2025
- Supernus Pharmaceuticals Reports Officer and Director Changes — 8-K · Aug 4, 2025
- Supernus Pharmaceuticals Completes Asset Acquisition — 8-K · Jul 31, 2025
- Supernus Pharmaceuticals Files 8-K on Financials — 8-K · Jul 22, 2025
- Supernus Pharmaceuticals Files 8-K for Shareholder Vote & Exhibits — 8-K · Jun 17, 2025
- Supernus Pharmaceuticals Files 8-K — 8-K · Jun 16, 2025
- Supernus Pharmaceuticals Files 8-K — 8-K · May 28, 2025
- Supernus Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 6, 2025
- Supernus Pharma Files Proxy Statement — DEF 14A · Apr 30, 2025
- Supernus Pharmaceuticals Files 8-K on Financial Condition — 8-K · Apr 23, 2025
- Supernus Pharmaceuticals Files 2024 10-K — 10-K · Feb 25, 2025
- Supernus Pharmaceuticals Files 8-K on Director Changes — 8-K · Feb 24, 2025
- Supernus Pharmaceuticals Files 8-K — 8-K · Feb 18, 2025
- Supernus Pharmaceuticals Files 8-K on Financials — 8-K · Feb 11, 2025
- Supernus Pharmaceuticals Files 8-K Report — 8-K · Feb 4, 2025
- Supernus Pharmaceuticals Files 8-K — 8-K · Jan 27, 2025